3161 - 3170 of 4301 Drugs
Lumason (sulfur hexafluoride lipid-type a microspheres injectable suspension)
Lumason (sulfur hexafluoride lipid-type A microspheres) is an ultrasound contrast agent indicated for use in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms, and in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients.
Lumi-Sporyn (neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment)
Lumi-Sporyn (neomycin and polymyxin B sulfates and bacitracin zinc ophthalmic ointment) is an antimicrobial ointment used for topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections include conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.
Lumoxiti (moxetumomab pasudotox-tdfk for injection)
Lumoxiti (moxetumomab pasudotox-tdfk) is a CD22-directed cytotoxin indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA).
Lumryz (sodium oxybate for extended-release oral suspension)
Lumryz (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy.
Lunsumio (mosunetuzumab-axgb injection)
Lunsumio (mosunetuzumab-axgb) is a bispecific CD20-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.
Lupkynis (voclosporin capsules)
Lupkynis (voclosporin) is a calcineurin-inhibitor immunosuppressant indicated in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis (LN).
Zepzelca (lurbinectedin for injection)
Zepzelca (lurbinectedin) is an alkylating drug used to treat adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
Reblozyl (luspatercept-aamt for injection)
Reblozyl (luspatercept-aamt) is an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions, for anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low-to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions, and for anemia failing an erythropoiesis stimulating agent and requiring 2 or more RBC units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
Mulpleta (lusutrombopag tablets)
Mulpleta (lusutrombopag tablets) is a thrombopoietin receptor agonist indicated for the treatment of low platelet counts (thrombocytopenia) in adult patients with chronic liver disease who are scheduled to undergo a procedure.
Lutathera (lutetium lu 177 dotatate injection)
Lutathera (lutetium Lu 177 dotatate) Injection is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastro-enteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in adults.